Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gotham Enhanced 500 ETF
GSPY
|
+$66.1M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25M |
| 3 |
PPL
PPL Corp
PPL
|
+$13.6M |
| 4 |
eBay
EBAY
|
+$9.93M |
| 5 |
Marathon Petroleum
MPC
|
+$9.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$8.58M |
| 2 |
United Rentals
URI
|
+$8.1M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.05M |
| 4 |
Honeywell
HON
|
+$6.98M |
| 5 |
Howmet Aerospace
HWM
|
+$6.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Healthcare | 13.87% |
| 3 | Consumer Discretionary | 13.13% |
| 4 | Industrials | 11.7% |
| 5 | Consumer Staples | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STL
876
DELISTED
Sterling Bancorp
STL
| $270K | 0.01% |
+10,801
| New | +$245K |
|
877
Trade Desk
TTD
$6.19B
| $269K | 0.01% |
3,820
| – | – |
|
878
Denali Therapeutics
DNLI
$3.98B
| $268K | 0.01% |
5,317
-4,222
| -44% | -$238K |
|
879
Tractor Supply
TSCO
$18.2B
| $266K | 0.01% |
6,555
-4,440
| -40% | -$172K |
|
880
Group 1 Automotive
GPI
$3.12B
| $265K | 0.01% |
1,411
-1,567
| -53% | -$266K |
|
881
Restaurant Brands International
QSR
$28.2B
| $264K | 0.01% |
+4,316
| New | +$276K |
|
882
Phillips 66
PSX
$96.9B
| $263K | 0.01% |
+3,762
| New | +$272K |
|
883
Warner Music
WMG
$14.2B
| $263K | 0.01% |
6,143
-10,485
| -63% | -$399K |
|
884
Century Communities
CCS
$1.98B
| $262K | 0.01% |
4,271
+155
| +4% | +$10.3K |
|
885
Comfort Systems
FIX
$58.3B
| $262K | 0.01% |
3,678
-3,149
| -46% | -$234K |
|
886
BCE
BCE
$22.1B
| $261K | 0.01% |
5,211
-12,079
| -70% | -$611K |
|
887
Allison Transmission
ALSN
$11B
| $260K | 0.01% |
+7,357
| New | +$281K |
|
888
Emergent Biosolutions
EBS
$260M
| $258K | 0.01% |
5,150
-8,218
| -61% | -$498K |
|
889
Hudbay
HBM
$13.4B
| $258K | 0.01% |
41,366
+26,048
| +170% | +$165K |
|
890
Steven Madden
SHOO
$3.37B
| $258K | 0.01% |
6,424
-7,892
| -55% | -$326K |
|
|
MRTX
891
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $257K | 0.01% |
1,455
-452
| -24% | -$72.7K |
|
|
SYNH
892
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $256K | 0.01% |
2,921
-4,485
| -61% | -$406K |
|
893
Commault Systems
CVLT
$5.55B
| $255K | 0.01% |
3,382
-913
| -21% | -$70.8K |
|
894
Erie Indemnity
ERIE
$13.8B
| $253K | 0.01% |
+1,416
| New | +$256K |
|
895
Natera
NTRA
$47.9B
| $252K | 0.01% |
+2,261
| New | +$259K |
|
896
SiriusXM
SIRI
$9.67B
| $252K | 0.01% |
+4,125
| New | +$259K |
|
897
Ecolab
ECL
$78.9B
| $251K | 0.01% |
1,205
-32
| -3% | -$7.01K |
|
898
BioMarin Pharmaceuticals
BMRN
$12.9B
| $250K | 0.01% |
+3,241
| New | +$256K |
|
899
Motorola Solutions
MSI
$79.5B
| $250K | 0.01% |
1,078
+54
| +5% | +$12.5K |
|
|
LHCG
900
DELISTED
LHC Group LLC
LHCG
| $250K | 0.01% |
1,593
-2,901
| -65% | -$545K |
|
Similar funds
Joel Greenblatt's Q3 2021 Portfolio in Review
As of Q3 2021, Joel Greenblatt held 1,165 positions worth $2.47B, up 4.5% from $2.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Joel Greenblatt deployed $147M of net new capital in Q3 2021, opening 183 new positions and adding to 380 existing holdings. Its largest new stake was Gotham Enhanced 500 ETF: 2,782,209 shares worth $64.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was FedEx, an estimated $8.58M trimmed.
- Joel Greenblatt's largest Q3 2021 buy was Gotham Enhanced 500 ETF: 2,782,209 shares worth $64.4M.
- Joel Greenblatt added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $25M increase.
- Joel Greenblatt's biggest Q3 2021 reduction was FedEx, cutting an estimated $8.58M.
- Joel Greenblatt fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $8.05M.
- Joel Greenblatt's ten largest holdings make up 16% of its $2.47B portfolio in Q3 2021.
- Joel Greenblatt opened 183 new positions and closed 160 in Q3 2021.
- Joel Greenblatt's portfolio value rose 4.5% quarter-over-quarter to $2.47B.
Based on Gotham Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.